Other non-strategic businesses — Revenue
Cencora Other non-strategic businesses — Revenue decreased by 5.8% to $619.78M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A decrease in this revenue is generally expected as the company divests or phases out non-core assets to focus on its primary pharmaceutical distribution business. An unexpected increase may indicate the retention of legacy assets or the emergence of new, non-strategic business lines.
Detailed definition
This metric represents the total revenue generated from business units or service lines that are considered non-core to...
Peer comparison
Peers in the pharmaceutical wholesale industry often report similar figures under 'discontinued operations' or 'other non-core segments' as they streamline their portfolios to focus on core supply chain and specialty services.
cor_segment_other_non_strategic_businesses_revenueHistorical Data
| Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $622.47M | $593.38M | $657.63M | $619.78M |
| QoQ Change | — | -4.7% | +10.8% | -5.8% |
| YoY Change | — | — | +5.6% | +4.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Cencora's other non-strategic businesses — revenue?
- Cencora (COR) reported other non-strategic businesses — revenue of $619.78M in Q1 2026.
- What does other non-strategic businesses — revenue mean?
- Revenue generated from business activities that are not part of the company's primary strategic focus.